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Abstract 
Context 
Over the last decade, robot-assisted adrenalectomy has been included in the surgical armamentarium for 
the management of adrenal masses. 
Objective 
To critically analyze the available evidence of studies comparing laparoscopic and robotic adrenalectomy. 
Evidence acquisition 
A systematic literature review was performed in August 2013 using PubMed, Scopus, and Web of Science 
electronic search engines. Article selection proceeded according to the search strategy based on 
Preferred Reporting Items for Systematic Reviews and Meta-analysis criteria. 
Evidence synthesis 
Nine studies were selected for the analysis including 600 patients who underwent minimally invasive 
adrenalectomy (277 robot assisted and 323 laparoscopic). Only one of the studies was a randomized 
clinical trial (RCT) but of low quality according to the Jadad scale. However, the methodological quality of 
included nonrandomized studies was relatively high. Body mass index was higher for the laparoscopic 
group (weighted mean difference [WMD]: −2.37; 95% confidence interval [CI], − 3.01 to −1.74; p < 
0.00001). A transperitoneal approach was mostly used for both techniques (72.5% of robotic cases and 
75.5% of laparoscopic cases; p = 0.27). There was no significant difference between the two groups in 
terms of conversion rate (odds ratio [OR]: 0.82; 95% CI, 0.39–1.75; p = 0.61) and operative time (WMD: 
5.88; 95% CI, −6.02 to 17.79; p = 0.33). There was a significantly longer hospital stay in the conventional 
laparoscopic group (WMD: −0.43; 95% CI, −0.56 to −0.30; p < 0.00001), as well as a higher estimated 
blood loss (WMD: −18.21; 95% CI, −29.11 to −7.32; p = 0.001). There was also no statistically significant 
difference in terms of postoperative complication rate (OR: 0.04; 95% CI, −0.07 to −0.00; p = 0.05) 
between groups. Most of the postoperative complications were minor (80% for the robotic group and 68% 
for the conventional laparoscopic group). Limitations of the present analysis are the limited sample size 
and including only one low-quality RCT. 
Conclusions 
Robot-assisted adrenalectomy can be performed safely and effectively with operative time and conversion 
rates similar to laparoscopic adrenalectomy. In addition, it can provide potential advantages of a shorter 
hospital stay, less blood loss, and lower occurrence of postoperative complications. These findings seem 
to support the use of robotics for the minimally invasive surgical management of adrenal masses. 
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1. Introduction 
Laparoscopic adrenalectomy was first reported in 1992. Since then it has largely replaced the open 
approach as the standard of care for adrenal removal, given well-known advantages such as less 
postoperative pain, minor blood loss, and better cosmetic appearance [1]. Nevertheless, laparoscopy is 
recognized as associated with a steep learning curve [2]. In 1999, Piazza et al. [3] and Hubens et al. [4] 
described the first robotic adrenalectomy cases using the AESOP 2000, which was the commercially 
available robotic platform in Europe at that time. 
With the introduction of the da Vinci system (Intuitive Surgical, Sunnyvale, CA, USA), several series of 
robotic adrenalectomy have been reported, showing the safety and feasibility of the procedure as well as 
potential advantages over laparoscopy, given the unique features of the currently available robotic system, 
such as three-dimensional vision and the EndoWrist technique [5]. 
Robotic surgery in urology has been mainly used to date for procedures involving reconstruction such as 
radical prostatectomy and partial nephrectomy, whereas its use for extirpative procedures such as 
nephrectomy and adrenalectomy has been limited, mainly because of cost issues [6]. 
The aim of this study was to review systematically the available evidence comparing the surgical outcomes 
of robot-assisted adrenalectomy with those of conventional laparoscopic adrenalectomy. 
2. Evidence acquisition 
2.1. Literature search and study selection 
A systematic literature review was performed in August 2013 using the PubMed, Scopus, and Web of 
Science databases to identify relevant studies. Searches were restricted to publications in English. Two 
separate searches were done by applying a free-text protocol with the following search terms: robotic 
adrenalectomy and robot-assisted adrenalectomy. 
Article selection proceeded according to the search strategy based on Preferred Reporting Items for 
Systematic Reviews and Meta-analysis criteria (www.prisma-statement.org) (Fig. 1). Only studies 
comparing robot-assisted and laparoscopic techniques were included for further screening. Cited 
references from the selected articles retrieved in the search were also assessed for significant papers. 
Conference abstracts were not included because they were not deemed to be methodologically 
appropriate. Two independent reviewers completed this process, and all disagreements were resolved by 
their consensus. 
2.2. Study quality assessment 
The level of evidence was rated for each included study according to the criteria provided by the Oxford 
Center for Evidence-Based Medicine [7]. The methodological quality of the studies was assessed using 
the Newcastle-Ottawa Scale (NOS) for non–randomized controlled trials (RCTs) [8] and the Jadad scale 
for RCTs [9]. 
2.3. Data extraction and outcomes of interest 
Two reviewers reviewed the full texts of the included studies. Preoperative demographic characteristics as 
well as perioperative and postoperative outcomes between the two procedures were compared. Data were 
extracted from each eligible study: age, gender, body mass index (BMI), side, past history of abdominal 
surgery, tumor size, operative time, estimated blood loss, length of hospital stay, conversion (defined as a 
procedure not completed using a technique different from the one initially planned and used), and 
complication rates. 
Postoperative complications were reported during the hospital stay and within 30 d after surgery, and they 
were classified according to the Clavien-Dindo grading system [10]. 
2.4. Statistical analysis 
A meta-analysis was performed to assess the outcomes of robot-assisted adrenalectomy when compared 
with laparoscopy. Odds ratio (OR) or risk ratio was used for binary variables, and mean difference or 
standardized mean difference was used for the continuous parameters. 
For studies presenting continuous data as means and range, standard deviations were calculated using 
the methodology described by Hozo and associates [11]. Pooled estimates were calculated with the fixed-
effect model (Mantel-Haenszel method) [12] if no significant heterogeneity was detected; otherwise, the 
random-effect model (DerSimonian-Laird method) was used [13]. 
The pooled effects were determined by the z test; p < 0.05 was considered statistically significant. The 
Cochrane chi-square test and inconsistency (I2) were used to evaluate the heterogeneity among studies. 
Data analysis was performed with Review Manager software (RevMan v.5.1, Cochrane Collaboration, 
Oxford, UK). 
2.5. Description of included studies and quality assessment 
Nine studies were selected for the analysis including 600 patients who underwent an adrenalectomy 
procedure for an adrenal mass. Overall, 277 robot-assisted cases (46%) and 323 laparoscopic cases 
(54%) were included. 
All except one of the included studies were observational retrospective comparative studies. Five of them 
compared consecutive series of patients (level of evidence [LE]: 3a) [14], [15], [16], [17] and [18], and two 
performed a retrospective nonconsecutive study (LE: 3b) [19] and [20]. Only one of the studies was an 
RCT (LE: 2b) [21]. 
The da Vinci system was used in all included studies. One study using the Zeus platform was excluded 
from the analysis [22]. 
The methodological quality of included studies was relatively high for the nonrandomized studies, whereas 
the only RCT was found to be of low quality (Table 1). 
3. Evidence synthesis 
3.1. Patient demographics and perioperative outcomes 
Table 2 presents the demographics of the studies. There was no significant difference between the two 
groups for any of the demographic parameters, except for the BMI, which was higher for the laparoscopic 
group (weighted mean difference [WMD]: −2.37; 95% confidence interval [CI], − 3.01 to −1.74]; p < 
0.00001). The transperitoneal approach was mostly used for both techniques (72.5% of robotic cases and 
75.5% of laparoscopic cases; OR: 1.20; 95% CI, 0.87–1.67; p = 0.27). 
length, conversion, and postoperative complications rates. 
 
 
 There was no significant difference between the two groups in terms of conversion rate (OR: 0.82; 95% CI, 
0.39–1.75; p = 0.61) ( Fig. 2) and operative time (WMD: 5.88; 95% CI, −6.02 to 17.79; p = 0.33) ( Fig. 3). 
There was a significantly longer hospital stay in the conventional laparoscopic group (WMD: −0.43; 95% 
CI, −0.56 to −0.30; p < 0.00001) ( Fig. 4) and higher estimated blood loss in this same group (WMD: 
−18.21; 95% CI, −29.11 to −7.32; p = 0.001) ( Fig. 5). 
There was also a trend favoring robot-assisted surgery for postoperative complications, but the p value did 
not reach statistical significance (OR: −0.04; 95% CI, −0.07 to −0.00; p = 0.05) ( Fig. 6). Most of the 
postoperative complications were minor (Clavien grade 1 and 2) in both groups (80% for the robotic group 
and 68% for the conventional laparoscopic group). There were two cases of Clavien grade 3 in the robotic 
group, and two cases of grade 4 and three cases of grade 5 occurred in the laparoscopic group. 
 
3.2. Critical analysis 
With the advent of the da Vinci system, robotic surgery has rapidly increased in popularity worldwide, 
initially for radical prostatectomy and later also for a wide range of procedures, especially those requiring 
advanced laparoscopic reconstructive skills, such as partial nephrectomy and pyeloplasty. Well-described 
advantages of robot-assisted over conventional laparoscopy include stereoscopic vision, filtration of 
tremor, and 7 degrees of freedom [6]. Our institution reported its initial experience with robotic 
adrenalectomy in the porcine model in 2000 [23] and 2 yr later in the clinical setting [2]. 
Since then, the feasibility and safety of minimally invasive adrenalectomy using the robot-assisted 
technique has been widely demonstrated by several series from different centers [5]. We systematically 
reviewed the outcomes of robotic and laparoscopic adrenalectomy, and performed a meta-analysis of 
nine eligible studies published between 2004 and 2013 including 600 patients. Only one RCT of low 
quality was identified. The authors did not describe the method of randomization and also did not report 
how the study was powered [21]. 
We observed no significant difference between the two techniques in terms of baseline characteristics, 
except for BMI, which was significantly lower in the robotic group (p < 0.00001). This can be regarded as 
a selection bias, and it is intuitively explained by the fact that surgeons initially tried to avoid obese 
patients early in their robotic experience. In a landmark analysis of the American College of Surgeons-
National Surgical Quality Improvement Project data set of >1600 adrenalectomy patients, Kazaure et al. 
examined the impact of obesity on 30-d outcomes of adrenalectomy [24]. Obesity represented an 
independent risk factor that needs to be considered in surgical decisions regarding adrenalectomy. Only a 
few reports have specifically addressed the use of robotic adrenalectomy in obese patients. Brunaud et 
al. pointed out that the robotic approach offered advantages in obese patients as well and that they did 
not encounter any technical difficulty in their patients with a mean BMI of 30 kg/m2 (maximum of 44 
kg/m2 in their series) [17]. In contrast, Aksoy et al. reported no significant difference in perioperative 
outcomes between robot-assisted surgery and laparoscopy in obese patients undergoing adrenalectomy 
[16]. These authors experienced difficulty using the same robotic trocar configurations in obese patients 
due to the need for retraction of the spleen and liver compared with normal-weight individuals. 
Overall, we found no statistically significant difference in the operative time between the two techniques 
(WMD: 5.88; 95% CI, −6.02 to 17.79; p = 0.33). The slight difference in terms of time can be related to the 
necessity of robot setup and docking time for the robotic procedure. However, this is likely to have a 
lesser impact on the overall operative time as the surgical experience with the use of the robot 
progresses. Brunaud et al. analyzed operative time according to the learning curve [17]. When 
considering only the first 20 procedures, they observed a significant difference between the groups 
favoring laparoscopy, whereas this difference was no longer detectable for the following 20 procedures. 
Agcaoglu et al. reported a significant improvement in operative time after the 10th procedure in the 
robot-assisted group [15]. In all the studies included in this review, the laparoscopic groups represented a 
more mature learning curve in comparison with robotic adrenalectomy. This fact may have biased some 
of the outcomes favoring laparoscopy. In the Karabulut et al. study, 28 cases were performed by two 
groups of staff (OR time = 142 ± 12 min) and 22 cases were done by one group of staff and one fellow 
(OR time: 201 ± 12 min); the difference in operative time was significantly different (p = 0.002) [18]. 
Agcaoglu et al. also reported the presence of a fellow or a resident in almost 50% of surgeries in both 
groups, but this fact did not affect the operative time significantly [14]. 
A low conversion rate was reported in all studies for both techniques (4.4% conversion rate for the 
robotic group and 7.1% for the laparoscopic group; (OR: 0.82; 95% CI, 0.39–1.75; p = 0.61). In the 
Brunaud et al. study, all four robot conversions were to the laparoscopic approach [17]. Morino et al. 
reported five conversions in the laparoscopic group including four to hand-assisted laparoscopy and one 
to open surgery [21]. Two studies had no conversions in both groups [15] and [20]. Aliyev et al., who 
compared both techniques only for pheochromocytomas surgeries, reported one case (3.9%) of 
conversion for the robotic group that was related to the adherence of tumor to surrounding strictures. 
The laparoscopic group presented three cases of conversion (7.5%) due to bleeding from tumor, bleeding 
from accessory renal vein, and difficulty with the dissection plane [25]. 
Morino et al. reported four cases of conversion in the robotic group (40%), three of them among the first 
five cases. The authors noted a statistically significant decrease in the conversion rate with increasing 
surgical experience [21]. 
The robotic approach provided significantly shorter hospitalization, which resulted in about a half-day 
less than for laparoscopy (WMD: −0.43 d; p < 0.0001). This could be regarded as a cost-saving feature. 
However, it should also be recognized that hospital stay can be influenced by a variety of factors other 
than the actual surgical procedure. 
The other significant outcome in favor of robotic surgery was the lower estimated blood loss, with a 
difference between groups reaching statistical significance (p = 0.001); seven of the nine studies reported 
less bleeding for robotics [14], [15], [16], [17], [18] and [19]. However, the detected difference of about 
25 ml is not clinically relevant. Thus it can be concluded that both techniques are quite safe and 
associated with minimal blood loss. 
There was a higher complication rate in the laparoscopic group (6.8% vs 3.6%), but it did not achieve 
significant statistical difference (OR: 0.04; 95% CI, −0.07 to −0.00; p = 0.05). There were more severe 
complications in the laparoscopic group, according to the Clavien grading system, including three deaths 
(Clavien grade 5), two resulting from respiratory failure due to severe pulmonary hypertension [16] and 
[18] and one from cardiac arrest [25]. You et al. reported two grade 4 complications in the laparoscopic 
group (acute kidney failure and cerebral infarction) requiring intensive care unit treatment [20]. In the 
robot-assisted group, there was one grade 3 complication in two studies [16] and [17]. In his RCT study, 
Morino et al. demonstrated that robot-assisted surgery is comparable with conventional laparoscopy in 
terms of postoperative morbidity and mortality [21]. 
The role of minimally invasive surgery for the management of malignant adrenal disease has been 
debated and remains a key issue. In a multicenter study, Greco et al. demonstrated that laparoscopic 
surgery for malignant adrenal tumors should be performed only in high-volume centers with at least ≥10 
adrenalectomies per year [26]. We did not specifically analyze and compare oncologic outcomes from the 
studies included in the present meta-analysis because only two of them partially reported on these 
outcomes. Agcoaglu et al. followed three patients with adrenocortical carcinoma (one from the robotic 
group and two from the laparoscopic group). The patient in the robotic group died after 18 mo of follow-
up presenting multifocal recurrence. The other two patients, from the laparoscopic arm, remained alive 
after 9 mo and 49 mo, respectively, of follow-up (one with no recurrence, and the second underwent 
resection and chemotherapy for recurrence after 6 mo) [14]. Aliyev et al. reported a median follow-up of 
12 mo for pheochromocytoma patients. Only one patient with a succinate dehydrogenase complex 
subunit B mutation developed systemic recurrence associated with elevated metanephrine levels, 
without local recurrence, at 5 mo. Follow-up for plasma metanephrine levels was similar between the 
two groups [25]. 
We must acknowledge that, in general, meta-analyses carry limitations. Most of the studies included in 
this review were retrospective nonrandomized comparisons, with an inherent potential risk of selection 
bias. Ideally, meta-analysis of RCTs would provide more reliable comparisons and enable stronger 
recommendations. However, due to the increased complexity to implement this type of study design, 
especially those comparing surgical techniques, they are few in the literature. Only one RCT was 
identified and included in the present meta-analysis, and it was of low quality [21]. 
Although the conversion and complication rates had low heterogeneity (I2 = 0% and 0%, respectively), 
the operative time, hospital stay, and estimated blood loss had high heterogeneity (I2 = 96%, 88%, and 
90%, respectively). Factors that could potentially explain the heterogeneity among the studies include 
surgeries conducted by several surgeons with different levels of experience, the shorter learning curve 
for the robotic group, the variety of treated diseases (benign, malignant, functioning, and nonfunctioning 
adrenal masses). It can be argued that the sample used for the present analysis is limited, so that the 
some of the differences between the two study groups might have remained undetected or 
underestimated. Similarly, differences detected in some of the parameters might have not reached a 
statistical significance, given the small number of cases. However, clinical significance, besides the 
statistical significance itself, should always be taken into account when analyzing surgical outcomes. 
Besides the surgical outcomes, cost remains an important drawback associated with robotic surgery, and 
this issue remains to be further scrutinized. Brunaud et al. calculated that the robotic adrenalectomy 
procedure was 2.3 times more costly in their experience than laparoscopy. They also calculated that a 
way to reach cost equivalence would be to increase da Vinci use, which means that capital and 
maintenance costs can become affordable at centers performing high-volume robotic surgery [17]. 
4. Conclusions 
Systematic review and a meta-analysis of current evidence show that robot-assisted adrenalectomy can 
be performed safely and effectively with operative time and complication rates similar to laparoscopic 
adrenalectomy. In addition it can provide the potential advantage of a shorter hospital stay and less 
blood loss. These findings seem to support the use of robotic surgery for the minimally invasive surgical 
management of adrenal masses. However, they should be confirmed in well-designed prospective RCTs 
with adequate power and follow-up. 
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